Member Info for solow

Alde sounds a lot to me like Trump ranting on Truth Social. I am guessing Alde also ace'd the Cognitive Test and now thinks he is a genius. Nice one Alde!

you must try harder not to be a **** pumpky. we are not waiting on news of recruitment but of injection or initial safety.

There is only 1 burner at hemo and it is firmly at the back. Vlad cooks up some good stuff but it takes a long time.

I few things to add to HereforHemo. The tech transfer to Cellin was to begin imminently as per RNS 28 April. I would think it has begun by now even considering how slow Hemo moves. The tech transfer is one of the steps needed before a definitive agreement is signed. IMO it shows a marked confidence in the drug from both Cellin and Hemp.

I would question 2 patients a month claim. I think even 2 patients every 2 months would be quite an achievement. However, this will be incidental once the 2nd cohort results are finalised. The picture by then will be very clear. IMO of course.

Goodness gracious me one4one, you do write a lot for someone so stupid.

Very funny JHFH! As magnificent as Vladdles is, there are a few things that are not in his control. Long term efficacy being one. And so a patient update would be nice :)

Seems our friend Lostmorethanapound got burnt more than a few times in the stockmarket and is terribly bitter. He will always be trying to twist the knife, no matter how high the share price goes. He will just be more bitter with each bits of good news and each rise in share price. The only comfort will be the joy he gets from annoying people. What a miserable way to live life. We should feel sorry for him.

We have a 15 August 2025 RNS stating that patients 1 and 2 were alive after 6 and 3 months respectively. I think we can be forgiven for expecting an RNS next week stating that patients 1 and 2 are alive after 12 and 9 months respectively. And that patient 3 is alive after 6 months. Alongside, I would think by month end, at the latest, we can expect news on Made and CDX. It is logical to think that the investors putting in 2.5 mil would have been given at least an implicit thumbs up from Vlad that everything is good. And so what a large, private placing tells us is that it will the news coming soon will be good :)

The important thing is that the company now enough capital to prove the science of Hgb-ct-1. End of. There is therefore no longer a funding risk as the funding is now sufficient to give this company more than enough resource to prove whether or not Car-T works. This is a big deal IMO.

I will take that as the end of conversation!

Lostaopound - not quite

CoPilot - There is no published timeline from Hemogenyx or Made Scientific, but based on industry norms for a CAR‑T tech transfer into an already CAR‑T‑equipped GMP facility, the realistic duration is about 3–6 months.

Pùmpkin you are so tedious. Do you and Lostapound live your clearly sad lives to annoy people? The following is again from Copilot

Because Made Scientific already operates GMP facilities specifically equipped for CAR‑T and other cell therapies, the technology transfer for Hemogenyx’s HG‑CT‑1 should be faster, smoother, and require far less facility adaptation than if the CDMO were starting from scratch.

Lostapound you miserable lowlife, I asked CoPilot about the Made transfer and this came back:

While Hemogenyx has not disclosed a timeframe, CAR‑T tech transfers to a CDMO typically take:

3–6 months for a straightforward transfer of an established process

6–12 months if process optimization, assay transfer, or facility adaptation is required

Longer if regulatory interactions or comparability studies are needed

But none of this is stated by Hemogenyx, so it cannot be treated as official guidance.

One4one, you have no credibility left. Go away.

Lostapound, you are clearly an unhappy individual. Are you worried about money? Down on your investments? Bad childhood. Most people have somethi g of this at times. But rather than trolling this group, why not just ask for help. You spend far too much time here on this board. You need to find something to do that gives you positive energy. Dont waste your life anymore. Go get therapy and deal with your problems.

The message takeaway is that Vlad anticipates that the trial will resume in Feb. This is obvs good news. For which Hemo will need funding. And funding is there waiting in the wings. Waiting and ready. And he wont fund itty nitty this time, he should fund raise for the whole year. There is no funding problem here. I suspect Alde and Notfor have given up de ramping because they could´t convince Vlad to take their heavily dilutive funding offer. Just a thought.

Anyhow, funding not an issue and trial restarting Feb. All good,

Why dont you have a look on companies house pumpkin and let us know?

Anyone who argues that Hemo has a funding issue needs their head read. When a HNW individual stocks up like this, you know the company wont be short of cash.

Welcome to Hemo where shareholders are treated like necessary annoyances. I recommend you ignore the short term noise and focus on the science because nothing else really matters.

Two of the 2000 sells are buys from me.